Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Friess currently holds 80,574 shares of HEMCURE INC (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Friess has been a net seller of NONE stock. They have purchased $0 and sold $1.3M worth of shares.
Michael Friess's most recent insider trade was on Oct 1, 2014, when they sold 1,530,901 shares at $0.02 per share.
Michael Friess serves as Executive at HEMCURE INC (NONE). They have executed 36 insider transactions totaling $1.3M over their tenure at the company.
Michael Friess holds the position of Executive at HEMCURE INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Michael Friess has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Friess was on May 14, 2008, when they sold $369.0K worth of CFDT shares. This transaction involved 286,085 shares at $1.29 per share.
Michael Friess currently owns 80,574 shares of HEMCURE INC (NONE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Friess's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Friess has 36 Form 4 filings on record as an insider at HEMCURE INC.
Set alerts for Michael Friess and 40,000+ other insiders.